BOLT — Bolt Biotherapeutics Cashflow Statement
0.000.00%
Last trade - 00:00- $13.55m
- -$33.77m
- $7.69m
- 22
- 57
- 14
- 21
Annual cashflow statement for Bolt Biotherapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -60.7 | -98.6 | -88.1 | -69.2 | -63.1 |
| Depreciation | |||||
| Non-Cash Items | 15.1 | 19.8 | 13 | 7.68 | 8.49 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -2.28 | 20.5 | -3.06 | -9.86 | -8.44 |
| Change in Prepaid Expenses | |||||
| Change in Accrued Expenses | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -47.3 | -57.1 | -76.5 | -69.5 | -61.3 |
| Capital Expenditures | -3.26 | -2.34 | -1.95 | -0.206 | -0.041 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -17.3 | -230 | 59.8 | 71.2 | 57.6 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Cash from Investing Activities | -20.6 | -232 | 57.9 | 71 | 57.6 |
| Financing Cash Flow Items | 39.3 | 0 | 0 | — | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 39.6 | 311 | 0.503 | 0.253 | 0.108 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -28.3 | 21.8 | -18.1 | 1.77 | -3.6 |